gemcitabine has been researched along with ginsenoside rg3 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, M; Huang, XB; Yi, C | 1 |
| Cui, DD; Huang, XB; Huang, Y; Ji, LL; Liu, TG; Mao, SH; Song, HB; Yi, C | 1 |
| Fan, QX; Huang, JY; Sun, Y; Zhang, YQ | 1 |
| Ahmmed, B; Faqeer, A; Kampo, S; Khan, M; Kumar, SP; Liu, JW; Yan, Q; Yulin, L | 1 |
| Fei, Z; Liang, X; Su, H; Zou, C; Zou, J | 1 |
1 trial(s) available for gemcitabine and ginsenoside rg3
| Article | Year |
|---|---|
[Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capsules; Cisplatin; Deoxycytidine; Esophageal Neoplasms; Female; Gemcitabine; Ginsenosides; Humans; Male; Middle Aged; Panax; Phytotherapy; Quality of Life; Survival Rate; Vascular Endothelial Growth Factor A | 2009 |
4 other study(ies) available for gemcitabine and ginsenoside rg3
| Article | Year |
|---|---|
[Experimental study on effect of chemotherapy combined ginsengnoside Rg3 in treating pulmonary carcinoma].
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Ginsenosides; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Transplantation | 2005 |
Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Growth Processes; Deoxycytidine; Female; Gemcitabine; Ginsenosides; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2009 |
Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3.
Topics: A549 Cells; C-Reactive Protein; Cell Movement; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; MAP Kinase Signaling System; Neoplasm Invasiveness; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Serum Amyloid P-Component; Signal Transduction | 2019 |
Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Ginsenosides; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; PTEN Phosphohydrolase; Signal Transduction; Transfection; Tumor Burden; Tumor Suppressor Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |